Zachary J. Williams
M.D./Ph.D. student
Vanderbilt University
From this contributor
Designing autism-friendly trials: Q&A with Caroline Averius and Zachary Williams
The pair’s new guidebook offers practical steps to make clinical trials easier and more meaningful for autistic participants.
Designing autism-friendly trials: Q&A with Caroline Averius and Zachary Williams
A new hub for participatory research: Q&A with Zachary Williams
Last month, the International Society for Autism Research launched the INSAR Community Collaborator Request (ICCR), an online forum to foster collaborations between autistic people and autism researchers. Its creator, Zachary Williams, explains how researchers can make the most of this new resource.
A new hub for participatory research: Q&A with Zachary Williams
Measuring alexithymia in autistic people
Despite the growing interest in alexithymia in autism research, the tools commonly used to measure this trait may not work reliably in autistic populations. A new scoring method fills that gap.
Measuring alexithymia in autistic people
Explore more from The Transmitter
How to teach programming in the age of AI
Scientists and educators are concerned about students using artificial intelligence to shortcut their learning. But there are also opportunities, especially when it comes to teaching neuroscience students how to code.
How to teach programming in the age of AI
Scientists and educators are concerned about students using artificial intelligence to shortcut their learning. But there are also opportunities, especially when it comes to teaching neuroscience students how to code.
Neuroscience conference policy draws confusion, apology
NeurIPS organizers apologized and altered course after issuing a policy that barred submissions from researchers at U.S.-government-sanctioned institutions.
Neuroscience conference policy draws confusion, apology
NeurIPS organizers apologized and altered course after issuing a policy that barred submissions from researchers at U.S.-government-sanctioned institutions.
Funding for animal research alternatives reaches ‘inflection point’
The United States and Europe are dedicating hundreds of millions of dollars in funding to advance novel alternative methods, but not all neuroscientists see this as a positive step.
Funding for animal research alternatives reaches ‘inflection point’
The United States and Europe are dedicating hundreds of millions of dollars in funding to advance novel alternative methods, but not all neuroscientists see this as a positive step.